Forbes September 11, 2024
Topline
Women with obesity and diabetes taking weight loss and diabetes drugs Mounjaro and Zepbound for over a year lost more weight than their male counterparts—but also experienced more nausea and vomiting, according to new research.
Key Facts
Researchers from Eli Lilly who tracked weight changes for a group of 4,677 people with Type 2 diabetes and obesity found female participants lost up to 24.6% of their body weight during treatment, while males lost up to 18.1% of their body weight.
The participants—2,999 females and 1,678 males—were followed for between 72 and 88 weeks, according to research presented this week at the Annual Meeting of The European Association for the Study of Diabetes.
These participants took...
Today's Sponsors
Today's Sponsor